These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9971767)

  • 41. A novel method for nucleos(t)ide analogues susceptibility assay of hepatitis B virus by viral polymerase transcomplementation.
    Luo YY; Tao Y; Cai XF; Zhang WL; Long QX; Guo H; Huang AL; Hu JL
    Antiviral Res; 2016 Feb; 126():99-107. PubMed ID: 26738784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutational analysis revealed that conservation of hepatitis B virus reverse transcriptase residue 306 (rtP306) is crucial for encapsidation of pregenomic RNA.
    Wang YX; Xu X; Luo C; Ma ZM; Jiang HL; Ding JP; Wen YM
    FEBS Lett; 2007 Feb; 581(3):558-64. PubMed ID: 17254572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HBV polymerase interacts independently with N-terminal and C-terminal fragments of Hsp90beta.
    Cho G; Suh SW; Jung G
    Biochem Biophys Res Commun; 2000 Jul; 274(1):203-11. PubMed ID: 10903919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of hepatitis B virus polymerase: requirement for distinct metal ions and the viral epsilon stem-loop.
    Urban M; McMillan DJ; Canning G; Newell A; Brown E; Mills JS; Jupp R
    J Gen Virol; 1998 May; 79 ( Pt 5)():1121-31. PubMed ID: 9603327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B viruses: reverse transcription a different way.
    Nassal M
    Virus Res; 2008 Jun; 134(1-2):235-49. PubMed ID: 18339439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Human monoclonal antibody inhibiting reverse transcriptase activity of hepatitis B virus polymerase protein].
    Park SJ; Seol SY; Jee SR; Park ET; Lee YJ; Lee SH; Chung JM; Cho HD; Jeong YJ; Choi IH; Park SG
    Korean J Gastroenterol; 2007 Feb; 49(2):85-92. PubMed ID: 17322787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluorescence-based biochemical analysis of human hepatitis B virus reverse transcriptase activity.
    Toyoda T; Wang Y; Wen Y; Tanaka Y
    Anal Biochem; 2020 May; 597():113642. PubMed ID: 32171777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of replication-competent hepatitis B virus nucleocapsids in insect cells.
    Seifer M; Hamatake R; Bifano M; Standring DN
    J Virol; 1998 Apr; 72(4):2765-76. PubMed ID: 9525596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinct requirement for two stages of protein-primed initiation of reverse transcription in hepadnaviruses.
    Wang X; Hu J
    J Virol; 2002 Jun; 76(12):5857-65. PubMed ID: 12021318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins.
    Hu J; Toft D; Anselmo D; Wang X
    J Virol; 2002 Jan; 76(1):269-79. PubMed ID: 11739692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase.
    Zoulim F; Seeger C
    J Virol; 1994 Jan; 68(1):6-13. PubMed ID: 7504742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis.
    Wang GH; Seeger C
    Cell; 1992 Nov; 71(4):663-70. PubMed ID: 1384989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of antibodies against DNA polymerase of hepatitis B virus in HBsAg-positive sera using ELISA.
    Rui LX; Park YM; Choi JY; Kim BS; Jung G
    Korean J Intern Med; 1998 Jul; 13(2):95-8. PubMed ID: 9735663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploiting new potential targets for anti-hepatitis B virus drugs.
    Wen YM; Lin X; Ma ZM
    Curr Drug Targets Infect Disord; 2003 Sep; 3(3):241-6. PubMed ID: 14529356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.
    Goedken ER; Marqusee S
    Proteins; 1998 Oct; 33(1):135-43. PubMed ID: 9741851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
    Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
    J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
    Shaw T; Mok SS; Locarnini SA
    Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients.
    Ji D; Liu Y; Si LL; Li L; Chen GF; Xin SJ; Zhao JM; Xu D
    Clin Chim Acta; 2011 Jan; 412(3-4):305-13. PubMed ID: 21056552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hsp90 makes the human HBV Pol competent for in vitro priming rather than maintaining the human HBV Pol/pregenomic RNA complex.
    Gyoo Park S; Kyung Rho J; Jung G
    Arch Biochem Biophys; 2002 May; 401(1):99-107. PubMed ID: 12054492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses.
    Wang GH; Zoulim F; Leber EH; Kitson J; Seeger C
    J Virol; 1994 Dec; 68(12):8437-42. PubMed ID: 7525990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.